corner
Healthy Skepticism
Join us to help reduce harm from misleading health information.
Increase font size   Decrease font size   Print-friendly view   Print
Register Log in

Healthy Skepticism Library item: 5456

Warning: This library includes all items relevant to health product marketing that we are aware of regardless of quality. Often we do not agree with all or part of the contents.

 

Publication type: news

Counseling better than pills for insomnia
Reuters 2006 Jun 28
http://www.msnbc.msn.com/id/13592904/


Notes:

Ralph Faggotter’s Comments:

In spite of the title (there is a lot more to CBT than counselling!), the point is well made that in the long run, CBT is better than pills, and without the adverse consequences in which the regular consumption of sleeping pills usually results.


Full text:

Counseling better than pills for insomnia
New study finds older adults sleep better with behavioral therapy
Reuters

Updated: 3:46 p.m. ET June 28, 2006
NEW YORK – Cognitive behavioral therapy (CBT), a counseling method that emphasizes the role of thinking and behavior modification, is more effective than zopiclone for the short- and long-term treatment of chronic insomnia in older adults, according to a new report. In fact, the study found that zopiclone was no more effect for insomnia than placebo was (a sugar pill.)

Zopiclone, sold under the trade name Imovane, is a central nervous system depressant. To prevent excessive drowsiness while using zopiclone, other CSN depressants, such as alcohol, should be avoided. Side effects that may particularly affect the elderly are confusion, unsteadiness and poor coordination.

Several studies have suggested that psychological and pharmacological interventions can improve insomnia, yet few studies have actually compared the two, Dr. Borge Sivertsen, from the University of Bergen in Norway, and colleagues note.

As reported in the Journal of the American Medical Association, the researchers assessed sleep outcomes in 46 insomnia patients, at least 55 years of age, who were randomly assigned to CBT, zopiclone or a placebo. The subjects were treated for 6 weeks and were followed for up to 6 months.

The features of CBT, which was conducted in weekly 50-minute sessions, included education about lifestyle factors that influence sleep, such as the importance of maintaining a strict sleep schedule and using the bedroom only when sleepy. The subjects were also taught to recognize and correct sleep misconceptions and how to perform progressive relaxation techniques.

After CBT, the percentage of time in bed actually spent sleeping, also referred to as sleep efficiency, increased from 81.4 percent at the beginning of the study to 90.1 percent at 6-month follow-up. By contrast, with zopiclone treatment, sleep efficiency actually worsened slightly, dropping from 82.3 percent to 81.9 percent.

Patients treated with CBT spent more time in the deepest stages of sleep and less time awake at night compared with patients in the zopiclone and placebo groups.

For most outcomes, zopiclone did no better than placebo, the authors point out.

These results suggest that CBT is superior to zopiclone for treating chronic insomnia in older adults, the authors conclude. They also suggest that future studies should try to identify the factors in the CBT regimen that produce the best results and if CBT sessions need to be repeated to maintain the improvements.

Copyright 2006 Reuters Limited. All rights reserved. Republication or redistribution of Reuters content is expressly prohibited without the prior written consent of Reuters.
URL: http://www.msnbc.msn.com/id/13592904/

 

  Healthy Skepticism on RSS   Healthy Skepticism on Facebook   Healthy Skepticism on Twitter

Please
Click to Register

(read more)

then
Click to Log in
for free access to more features of this website.

Forgot your username or password?

You are invited to
apply for membership
of Healthy Skepticism,
if you support our aims.

Pay a subscription

Support our work with a donation

Buy Healthy Skepticism T Shirts


If there is something you don't like, please tell us. If you like our work, please tell others.

Email a Friend








What these howls of outrage and hurt amount to is that the medical profession is distressed to find its high opinion of itself not shared by writers of [prescription] drug advertising. It would be a great step forward if doctors stopped bemoaning this attack on their professional maturity and began recognizing how thoroughly justified it is.
- Pierre R. Garai (advertising executive) 1963